NEW YORK – Swedish biotechnology firm Cartana is poised to grow its product portfolio and raise its profile thanks to its participation in several new Human Cell Atlas projects.
The Solna, Sweden-based company is currently expanding from offering in situ sequencing services to selling kits, and stands to benefit from such projects. As part of this change, in January it also named a new CEO, Mårten Winge, to manage commercialization. Winge had served as COO since September.